Page last updated: 2024-08-17

medroxyprogesterone acetate and HIV Coinfection

medroxyprogesterone acetate has been researched along with HIV Coinfection in 149 studies

Research

Studies (149)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (0.67)	18.2507
2000's	18 (12.08)	29.6817
2010's	100 (67.11)	24.3611
2020's	30 (20.13)	2.80

Authors

Authors	Studies
Dinh, C; García-Lerma, JG; Gary, MJ; Heneine, W; Khalil, GK; Luthra, R; McNicholl, JM; Mitchell, J; Morris, MM; Pereira, LE; Spreen, WR; Vishwanathan, SA; Zhao, C	1
Broliden, K; Clerici, M; Günaydın, G; Introini, A; Jangard, M; Margolis, L; Vanpouille, C	1
Baeten, JM; Beesham, I; Beksinka, M; Bukusi, E; Deese, J; Donnell, D; Edward, V; Heffron, R; Kourtis, AP; Morrison, C; Mugo, NR; Philip, NM; Rees, H; Scoville, CW; Stalter, RM	1
Baeten, JM; Bosinger, SE; Bunjun, R; Burgener, A; Dabee, S; Gamieldien, H; Happel, AU; Harryparsad, R; Heffron, R; Heller, K; Jaspan, HB; Jaumdally, SZ; Nair, G; Onono, M; Palanee-Phillips, T; Passmore, JAS; Qumbelo, Y; Scoville, CW; Sinkala, M; Tanko, RF	1
Ahmed, K; Bailey, V; Beksinska, M; Buck, G; Chen, PL; Deese, J; Gao, X; Harryparsad, R; Lefebvre d'Hellencourt, F; Masson, L; Mehou-Loko, C; Meyer, B; Morrison, C; Nanda, K; Radzey, N; Serrano, M; Smit, J; Strauss, J; Taku, O; Williamson, AL	1
Beksinska, ME; Brown, TT; Glenn Fowler, M; Kiwanuka, N; Kiweewa Matovu, F; Musoke, P; Nabwana, M; Pettifor, JM; Scholes, D	1
Åhlberg, A; Bergström, S; Bradley, F; Broliden, K; Czarnewski, P; Damdimopoulos, A; Edfeldt, G; Fowke, K; Franzén Boger, M; Kaldhusdal, V; Kimani, J; Lajoie, J; Månberg, A; Nilsson, P; Omollo, K; Oyugi, J; Tjernlund, A	1
Ayele, H; Baeten, JM; Bosinger, SE; Brown, BP; Bunjun, R; Burgener, A; Dabee, S; Gamieldien, H; Harryparsad, R; Heffron, R; Heller, KB; Jaspan, H; Jaumdally, SZ; Nair, G; Noël-Romas, L; Onono, M; Palanee-Phillips, T; Passmore, JS; Ramla, TF; Scoville, CW	1
Avenant, C; Bick, AJ; Hapgood, JP; Tomasicchio, M; van der Spuy, Z	1
Aung, W; Bakshi, RP; Bream, JH; Bumpus, NN; Coleman, JS; Diniz, CP; Farzadegan, H; Fuchs, EJ; Hendrix, CW; Hudson, S; Marzinke, MA; Nilles, TL; Rooney, JF; Rosenblum, MA; Schwartz, GJ	1
Chen, PL; Deese, J; Gao, X; Heffron, R; Hobbs, M; Jaspan, H; Lapple, D; Miller, A; Nair, G; Onono, M; Palanee-Phillips, T; Reddy, K; Steiner, MJ	1
Balle, C; Bosinger, SE; Burgener, AD; Dabee, S; Happel, AU; Heffron, R; Innes, S; Jaspan, H; Nair, G; Onono, M; Palanee-Phillips, T; Passmore, JS	1
Chinula, L; Corbett, AH; Cottrell, ML; Gajer, P; Haddad, LB; Hurst, S; Kourtis, AP; Lantz, AM; Nelson, JAE; Nicol, MR; Ravel, J; Tang, JH; Tegha, G	1
Badal-Faesen, S; Cohn, SE; Coughlin, K; Cramer, Y; Dooley, K; Firnhaber, C; Godfrey, C; Kendall, MA; Mawlana, S; Mcilleron, H; Mngqibisa, R; Omoz-Oarhe, A; Roa, J; Robinson, J; Rosenkranz, SL; Samaneka, W; Schnabel, D; Wu, XS	1
Abaasa, A; Fast, PE; Kaleebu, P; Mayanja, Y; Nash, S; Price, M; Todd, J	1
Beacroft, L; Hallett, TB; Smith, JA	1
Abbai, N; Hewlett, I; Mnqonywa, N; Moodley, D; Ragupathy, V; Ramjee, G	1
Hapgood, JP	3
Aceves, KM; Calla, NEQ; Cherpes, TL; Lopez, FCD; Miguel, RDV	1
Achilles, S; Balkus, JE; Marrazzo, J; Noguchi, L	1
Gollub, EL; Jones, H; Padian, N; Ralph, L; Stein, Z; van de Wijgert, JHHM	1
Gollub, EL; Hallett, TB; Jewell, BL; Jones, HE; Padian, NS; Ralph, LJ; Smith, JA; van de Wijgert, JHHM	1
Aceves, KM; Cherpes, TL; Gabriel, JM; Hatfield, AM; Kaur, B; Kwiek, JJ; Quispe Calla, NE; Torres, AR; Trout, W; Vicetti Miguel, RD	1
Cherpes, TL; Quispe Calla, NE; Vicetti Miguel, RD	1
Achilles, SL; Chen, BA; Hendrix, CW; Marzinke, MA; Meyn, LA; Tarleton, J	1
Åhlberg, A; Bradley, F; Broliden, K; Edfeldt, G; Fowke, KR; Khalilzadeh-Binicy, B; Kimani, J; Lajoie, J; Mack, M; Omollo, K; Oyugi, J; Röhl, M; Tjernlund, A; Wählby, C	1
Abdullah, F; Beacroft, L; Buthelezi, B; Hallett, TB; Makua, M; Morroni, C; Ramjee, G; Smith, JA; Velasquez, C	1
Bagri, P; Dupont, H; Kaushic, C; Lam, J; Nazli, A; Verschoor, CP; Woods, MW; Zahoor, MA	1
Cohn, SE; Denti, P; Dooley, KE; Firnhaber, C; Francis, J; Godfrey, C; Kendall, MA; McIlleron, H; Mngqibisa, R; Wu, X	1
Angira, F; Badal-Faesen, S; Baker, P; Cohn, SE; Denti, P; Francis, J; Haas, DW; Kendall, MA; Mawlana, S; McIlleron, H; Mngqibisa, R; Omoz-Oarhe, A; Robinson, JA; Samaneka, WP	1
Akello, CA; Balkus, JE; Bunge, KE; Celum, C; Chirenje, ZM; Fowler, MG; Marrazzo, J; Mirembe, BG; Mishra, A; Nakabiito, C	1
Baeten, JM; Balkus, JE; Brown, ER; Chappell, C; Harkoo, I; Jeenarain, N; Kabwigu, S; Kintu, K; Kiweewa, FM; Marzinke, M; Naidoo, L; Nair, G; Nakabiito, C; Palanee-Phillips, T; Reddy, K; Siva, S; Soto-Torres, L	1
Mhlongo, NN; Moonsamy, S; Soliman, MES; Takalani, F	1
Dizzell, S; Kaushic, C; Verschoor, CP; Woods, MW; Zahoor, MA	1
Achilles, SL; Hapgood, JP; Hel, Z; Polis, CB	1
Hapgood, JP; Hel, Z; Kaushic, C	1
Cherpes, TL; Gabriel, JM; Glick, ME; Kwiek, JJ; Quispe Calla, NE; Vicetti Miguel, RD	1
Chinula, L; Ellington, S; Haddad, LB; Hosseinipour, MC; Hurst, S; Kourtis, AP; Mataya, R; Msika, A; Nelson, JAE; Tang, JH; Tegha, G; Wiener, J	1
Anderson, S; Chen, PL; Chipato, T; Deese, J; Doncel, GF; Fichorova, R; Kwok, C; Morrison, CS; Salata, R; Yamamoto, H	1
Bosinger, SE; Butler, K; Dietz Ostergaard, S; Ellis, S; Johnson, RL; Kersh, EN; McNicholl, JM; Patel, NB; Payne, TL; Tharp, GK; Vishwanathan, SA; Zhao, C	1
Hofmeyr, GJ; Makua, M; Nene, Z; Panday, M; Patel, M; Pillay, Y; Rees, H	1
Brache, V; Chandra, N; Chen, BA; Doncel, GF; Kashuba, ADM; Mauck, C; Schwartz, JL; Thurman, AR; Weiner, DH	1
Adedipe, OE; Anderson, SM; Chandra, N; Doncel, GF; Fang, X; Jackson, SS; Mauck, CK; Schwartz, JL; Thurman, AR; Yousefieh, N; Zalenskaya, IA	1
Gollub, EL; Jones, HE; Padian, N; Ralph, LJ; Stein, Z; van de Wijgert, JHHM	1
Achilles, SL; Dorflinger, LJ; Hapgood, JP; Heffron, R; Kiarie, J; Polis, CB; Steyn, PS	1
Boily-Larouche, G; Broliden, K; Cheruiyot, J; Edfeldt, G; Fowke, KR; Kimani, J; Kimani, M; Lajoie, J; Omollo, K; Oyugi, J; Röhl, M; Tjernlund, A	1
Baeten, JM; Blue, SW; Davis, NL; Erikson, DW; Heffron, R; Hladik, F; Kourtis, AP; Lingappa, JR; Mugo, N; Nanda, K; Pyra, M; Stalter, R	1
Baiamonte, L; Drobnis, EZ; Hope, TJ; Huang, L; Li, L; Mills, M; Quayle, AJ; Schust, DJ; Stark, M; Tu, J; Wang, W; Zhou, J	1
Avenant, C; Dlamini, S; Hapgood, JP; Maritz, MF; Ray, RM; Tomasicchio, M; van der Spuy, Z	1
Asin, S; Brache, V; Chandra, N; Chen, BA; Doncel, GF; Fichorova, RN; Herold, BC; Hillier, SL; Mauck, C; Rollenhagen, C; Schwartz, JL; Thurman, A; Weiner, DH	1
Abbai, N; Boodhram, R; Moodley, D; Ramjee, G	1
Chinula, L; Corbett, A; Cottrell, ML; Haddad, LB; Hurst, S; Kourtis, AP; Msika, A; Nelson, JAE; Tang, JH; Wiener, J	1
Akers, J; Augustine, MS; Buckner, LR; Drobnis, EZ; Hope, TJ; Mott, PD; Quayle, AJ; Rogers, LK; Schust, DJ	1
Beksinska, M; Brown, TT; Eneh, P; Fowler, MG; Isingel, E; Kabwigu, S; Kaiser, T; Kiweewa Matovu, F; Nakalega, R; Nicol, MR; Staley, C; Sykes, C	1
Sathyamala, C	1
Chinula, L; Kourtis, AP; Stanczyk, FZ; Tang, JH; Tegha, G; Zia, Y	1
Bengtson, A; Byamugisha, J; Chipato, T; Kwok, C; Morrison, CS; Moyo, P; Rwambuya, S; Salata, RA	1
Morrison, CS; Turner, AN; van de Wijgert, JH; Verwijs, MC	1
Hallett, T; McCoy, SI; Padian, N; Ralph, LJ	1
Bryant, AG; Cwiak, C; Feldacker, C; Haddad, LB; Hoffman, I; Hosseinipour, M; Jamieson, DJ; Mayne, P; Mulundila, L; Noah, I; Phiri, S; Samala, B; Stuart, GS; Tweya, H	1
Gray, R; Kigozi, G; Kong, X; Lutalo, T; Makumbi, F; Musoke, R; Nalugoda, F; Sekasanvu, J; Serwadda, D; Sewankambo, N; Wawer, M	1
Gray, RH; Makumbi, F; Mondo, G; Nakawooya, H; Nakigozi, GF; Polis, CB	1
Cates, W	1
Gollub, EL; Stein, Z	1
Redd, AD	1
Hallett, T; McCoy, S; Padian, N; Ralph, L	1
Avenant, C; Govender, Y; Hapgood, JP; Ray, RM; Tomasicchio, M	1
Herold, BC; Irvin, SC; Murphy, K	1
Ferreira, VH; Kafka, JK; Kaushic, C	1
Agnew, K; Astronomo, R; Eschenbach, D; Gardella, C; Hladik, F; Mack, M; Magaret, A; McElrath, MJ; McLemore, L; Mitchell, CM; Patton, D; Smythe, K; Westerberg, K	1
Henning, TC; Kersh, EN; McNicholl, JM; Vishwanathan, SA	1
Chohan, V; Day, S; Graham, SM; Jaoko, W; Kiarie, JN; Mandaliya, K; Masese, LN; McClelland, RS; Overbaugh, J; Richardson, BA	1
Cooney, R; Hayward, P	1
Aravantinou, M; Blanchard, J; Derby, N; Gettie, A; Goode, D; Guerra-Perez, N; Jarl, S; Kenney, J; Martinelli, E; Robbiani, M; Truong, R	1
Jones, HE	1
Westhoff, CL; Winikoff, B	1
Curtis, KM; Hannaford, P; Phillips, SJ; Polis, CB; Raymond, E; Steyn, PS; Turner, AN; Westreich, DJ	1
Deyounks, F; Ellis, S; García-Lerma, JG; Hanley, K; Heneine, W; Jenkins, L; Mitchell, J; Radzio, J	1
Hofmeyr, GJ; Lawrie, TA; Singata-Madliki, M; Temmerman, M	1
Dinh, CT; Herold, BC; Kiser, PF; Lo, Y; Smith, JM; Srinivasan, P; Teller, RS	1
Baeten, JM; Bukusi, EA; Celum, C; Donnell, D; Frenkel, LM; Heffron, R; Kiarie, J; Mugo, N; Mujugira, A; Ronald, A; Were, E	1
Cochrane, A; Dizzell, S; Ferreira, VH; Kafka, JK; Kaushic, C; Mueller, K; Nazli, A; Nguyen, PV; Tremblay, MJ	1
Abou, M; Ball, TB; Fowke, KR; McCorrister, SJ; McKinnon, LR; Plummer, FA; Shaw, SY; Stein, DR; Westmacott, GR	1
Wise, J	1
Colvin, CJ; Harrison, A	1
McCoy, SI; Padian, NS; Ralph, LJ; Shiu, K	1
Baeten, JM; Brown, J; Chen, PL; Crook, AM; Delany-Moretlwe, S; Francis, SC; Friedland, BA; Hayes, RJ; Heffron, R; Kapiga, S; Karim, QA; Karpoff, S; Kaul, R; Kwok, C; Low, N; McClelland, RS; McCormack, S; McGrath, N; Morrison, CS; Myer, L; Rees, H; Stalter, R; Van Damme, L; van de Wijgert, JH; van der Straten, A; Watson-Jones, D	1
Aweeka, F; Cohn, SE; Cramer, Y; Klingman, KL; Livingston, E; Luque, AE; Park, JG; Watts, DH; Weinberg, A	1
Bebawy, SS; Castilho, JL; Jenkins, CA; Melekhin, VV; Shepherd, BE; Sterling, TR; Turner, M	1
Haddad, LB; Philpott-Jones, S; Schonfeld, T	1
Herold, BC; Irvin, SC	1
Chappell, CA; Dezzutti, CS; Hillier, SL; Isaacs, CE; Meyn, LA; Moncla, BJ; Uranker, K; Xu, W	1
Harper, KN	1
Ellman, TM; Myers, JE; Westhoff, C	1
Baeten, JM; Balkus, JE; Bunge, K; Chirenje, ZM; Gomez, K; Hillier, SL; Marrazzo, JM; Nair, G; Noguchi, LM; Palanee-Phillips, T; Parikh, UM; Piper, JM; Ramjee, G; Richardson, BA; Selepe, P; van der Straten, A; Watts, DH	1
Akatova, N; Curtis, KM; Hillis, SD; Jamieson, DJ; Jeng, G; Kissin, DM; Mandel, MG; Marchbanks, PA; Martirosyan, M; Samarina, A; Whiteman, MK	1
Abdellati, S; Agot, K; Ahmed, K; Cohen, M; Crucitti, T; Deese, J; Masson, L; Miller, W; Morrison, C; Van Damme, L; Wang, M	1
Aweeka, F; Bosch, R; Cho, A; Cohn, SE; Cramer, Y; Livingston, E; Luque, AE; Park, JG; Watts, DH; Weinberg, A	1
Jones, HE; van de Wijgert, JH	2
Averbach, S; Darney, P; Seidman, D; Smith-McCune, K	1
Hofmeyr, GJ; Lawrie, TA; Singata, M; Temmerman, M	1
Balkus, JE; Marrazzo, JM; Noguchi, LM; Richardson, BA	1
Schooling, CM	1
Brandão, Kde S; da Silva, CA; de Brito, Fde O; de Souza, EX; Haguihara, T; Lima, BG; Travassos, AG	1
Gollub, EL; Jones, HE; Ralph, LJ	1
Hickey, M; Marino, JL; Tachedjian, G	1
Dragoman, MV; Gaffield, ME	1
Agot, K; Callahan, R; Dorflinger, L; Jenkins, D; Nanda, K; Taylor, D; Van Damme, L; Wang, M	1
Baeten, JM; Celum, C; Donnell, D; Heffron, R; Mellors, JW; Mugo, N; Parikh, UM; Penrose, KJ	1
Dorflinger, L; Halpern, V; Schivone, G	1
Chinula, L; Corbett, A; De Paris, K; Ellington, S; Haddad, L; Hoffman, IF; Hosseinipour, M; Hurst, S; Jamieson, DJ; King, CC; Kourtis, AP; Nelson, JA; Tang, J; Wiener, J	1
Birse, KD; Bosire, R; Broliden, K; Burgener, AD; Farquhar, C; Guthrie, BL; Kiarie, J; Nilsson, P; Romas, LM	1
Averbach, S; Critchfield, JW; Giudice, LC; Greenblatt, RM; Hilton, JF; Seidman, D; Shacklett, BL; Shanmugasundaram, U; Smith-McCune, KK	1
Nurutdinova, D; Overton, ET; Shacham, E; Singhatiraj, E	1
Gisselquist, D	1
Anastos, K; Cohen, MH; Cole, SR; Fennie, K; Grey, M; Minkoff, H; Scherzer, R; Tien, PC; Williams, AB; Womack, JA	1
Hay, P; Majewska, W; Oakeshott, P; Varma, N; Varma, R	1
Hofmeyr, GJ; Lawrie, TA; Singata, M	1
Byamugisha, J; Celentano, DD; Chen, PL; Chipato, T; Kwok, C; Morrison, CS; Mugerwa, R; Padian, N; Richardson, BA; Salata, RA	1
Arts, E; Chen, PL; Chipato, T; Dunbar, M; Ma, YR; Morrison, CS; Mugerwa, R; Nankya, I; Rinaldi, A; Salata, RA; Van Der Pol, B	1
Byamugisha, J; Jones, L; Kwok, C; Magwali, T; Morrison, CS; Nanda, K; Sriplienchan, S	1
Guirguis-Blake, J	1
Chen, PL; Cole, SR; Morrison, CS	1
Boyd, P; Doyle, LA; Fetherston, SM; Geer, L; Goldman, L; Ketas, TJ; Klasse, PJ; Lowry, D; Major, I; Malcolm, RK; Moore, JP; Murphy, DJ; Rasmussen, KK; Shattock, RJ; Veazey, RS	1
Jain, AK	1
Boaz, I; Gray, RH; Lutalo, T; Makumbi, FE; Nakigozi, G; Ndyanabo, A; Polis, CB; Reynolds, SJ; Ssempijja, V; Wawer, MJ	1
Goepfert, PA; Hel, Z; Helton, ES; Huijbregts, RP; Michel, KG; Richter, HE; Sabbaj, S	1
Castaño, PM; Stuart, GS	1
Mauck, C	1
Achola, JO; Kreiss, JK; Mandaliya, K; Martin, HL; Overbaugh, J; Richardson, BA	1
Celentano, DD; Chipato, T; Mmiro, F; Morrison, CS; Mugerwa, R; Padian, NS; Richardson, BA; Rugpao, S; Salata, RA	1
McClelland, RS	1
Blanchard, J; Cheng-Mayer, C; Gettie, A; Harouse, J; Schneider, E; Simon, V; Trunova, N; Tsai, L; Tung, S	1
Brown, JM; Celentano, DD; Chipato, T; Cornelisse, P; Luoto, J; Mmiro, F; Morrison, CS; Mugerwa, R; Padian, N; Richardson, BA; Rugpao, S; Salata, RA	1
Denny, L; Kuhn, L; Myer, L; Wright, TC	1
Clax, PA; Cohn, SE; Hitti, J; Lertora, JJ; Park, JG; Stek, A; Watts, DH; Yu, S	1
Baeten, JM; Hassan, WM; Jaoko, W; Kiarie, J; Lavreys, L; Mandaliya, K; McClelland, RS; Ndinya-Achola, J; Sangare, L	1
Farquhar, C; John-Stewart, GC; Mbori-Ngacha, D; Otieno, PA; Overbaugh, J; Richardson, BA	1
Amaral, E; Bahamondes, L; Hays, M; Mehta, N; Nanda, K; Viscola, MA	1
Clax, PA; Cohn, SE; Hitti, J; Lertora, JJ; Muderspach, L; Park, JG; Stek, A; Watts, DH; Yu, S	1
Dubois-Colas, N; Garenne, M; Leclerc, PM	1
Cohen, J	1

Reviews

20 review(s) available for medroxyprogesterone acetate and HIV Coinfection

Article	Year
Update on the Impact of Depot Medroxyprogesterone Acetate on Vaginal Mucosal Endpoints and Relevance to Sexually Transmitted Infections. Current HIV/AIDS reports, 2023, Volume: 20, Issue:4 Topics: Bacteria; Contraceptive Agents, Female; Female; HIV Infections; Humans; Inflammation; Medroxyprogesterone Acetate; Mucous Membrane; Observational Studies as Topic	2023
Review on the Biological Mechanisms Associated with Depo-Provera and HIV-1 Risk Acquisition in Women. Cell biochemistry and biophysics, 2018, Volume: 76, Issue:1-2 Topics: Aniline Compounds; Anti-Retroviral Agents; Female; Genitalia, Female; HIV Infections; HIV-1; Humans; Medroxyprogesterone Acetate; NF-kappa B; Receptors, Glucocorticoid; Receptors, Progesterone; Risk Factors	2018
Hormonal Contraception and HIV-1 Acquisition: Biological Mechanisms. Endocrine reviews, 2018, 02-01, Volume: 39, Issue:1 Topics: Animals; Contraception; Contraceptive Agents, Female; Disease Susceptibility; Dose-Response Relationship, Drug; Female; Genitalia, Female; HIV Infections; HIV-1; Humans; Medroxyprogesterone Acetate; Progestins	2018
Hormonal contraception decreases bacterial vaginosis but oral contraception may increase candidiasis: implications for HIV transmission. AIDS (London, England), 2013, Aug-24, Volume: 27, Issue:13 Topics: Candidiasis, Vulvovaginal; Contraception; Contraceptives, Oral, Hormonal; Female; HIV Infections; Humans; Medroxyprogesterone Acetate; Risk Assessment; Vaginosis, Bacterial	2013
Differential glucocorticoid receptor-mediated effects on immunomodulatory gene expression by progestin contraceptives: implications for HIV-1 pathogenesis. American journal of reproductive immunology (New York, N.Y. : 1989), 2014, Volume: 71, Issue:6 Topics: Africa South of the Sahara; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Female; HIV Infections; HIV-1; Humans; Immunosuppression Therapy; Medroxyprogesterone Acetate; Norethindrone; Progesterone Congeners; Receptors, Glucocorticoid	2014
Research gaps in defining the biological link between HIV risk and hormonal contraception. American journal of reproductive immunology (New York, N.Y. : 1989), 2014, Volume: 72, Issue:2 Topics: Animals; Contraception; Contraceptive Agents, Female; Female; Herpes Genitalis; HIV Infections; Humans; Immunity, Mucosal; Intercellular Junctions; Medroxyprogesterone Acetate; Microbiota; Mucous Membrane; Permeability; Risk; Vagina	2014
Influence of common mucosal co-factors on HIV infection in the female genital tract. American journal of reproductive immunology (New York, N.Y. : 1989), 2014, Volume: 71, Issue:6 Topics: Contraceptives, Oral, Hormonal; Disease Susceptibility; Female; Genital Diseases, Female; Genitalia, Female; Gonadal Steroid Hormones; HIV Infections; Humans; Interferons; Medroxyprogesterone Acetate; Mucous Membrane; Semen; Tight Junctions	2014
Hormonal contraceptive methods and risk of HIV acquisition in women: a systematic review of epidemiological evidence. Contraception, 2014, Volume: 90, Issue:4 Topics: Administration, Oral; Africa; Condoms; Contraceptive Agents, Female; Female; HIV Infections; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Norethindrone	2014
Hormonal contraceptive use and women's risk of HIV acquisition: a meta-analysis of observational studies. The Lancet. Infectious diseases, 2015, Volume: 15, Issue:2 Topics: Adult; Contraceptive Agents, Female; Female; HIV Infections; Humans; Medroxyprogesterone Acetate; Middle Aged; Risk Assessment	2015
Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis. PLoS medicine, 2015, Volume: 12, Issue:1 Topics: Adolescent; Adult; Africa South of the Sahara; Contraceptive Agents, Female; Female; HIV Infections; Humans; Incidence; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Risk Factors	2015
Injectable agents for pre-exposure prophylaxis: lessons learned from contraception to inform HIV prevention. Current opinion in HIV and AIDS, 2015, Volume: 10, Issue:4 Topics: Anti-HIV Agents; Contraception; Female; HIV Infections; Humans; Male; Medroxyprogesterone Acetate; Pre-Exposure Prophylaxis	2015
Hormonal contraceptive use and women's risk of HIV acquisition: priorities emerging from recent data. Current opinion in obstetrics & gynecology, 2015, Volume: 27, Issue:6 Topics: Adult; Contraceptive Agents, Female; Female; Health Knowledge, Attitudes, Practice; Health Priorities; HIV Infections; Humans; Incidence; Medroxyprogesterone Acetate; Norethindrone; Public Health; Risk Assessment; Risk Factors; Sexual Behavior	2015
Critical Review: Mechanisms of HIV Transmission in Depo-Provera Users: The Likely Role of Hypoestrogenism. Journal of acquired immune deficiency syndromes (1999), 2016, Jan-01, Volume: 71, Issue:1 Topics: Contraceptive Agents, Female; Estrogens; Female; HIV Infections; Humans; Medroxyprogesterone Acetate; Vagina	2016
The safety of subcutaneously administered depot medroxyprogesterone acetate (104mg/0.65mL): A systematic review. Contraception, 2016, Volume: 94, Issue:3 Topics: Bone Density; Contraceptive Agents, Female; Delayed-Action Preparations; Endometriosis; Female; HIV Infections; Humans; Injections, Intramuscular; Injections, Subcutaneous; Medroxyprogesterone Acetate; Obesity; Pain; Patient Satisfaction; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Weight Gain; World Health Organization	2016
Injectable contraception: updates and innovation. Current opinion in obstetrics & gynecology, 2016, Volume: 28, Issue:6 Topics: Abortion, Induced; Adult; Contraception; Contraceptive Agents, Female; Drug Delivery Systems; Family Planning Services; Female; Health Services Accessibility; HIV Infections; Humans; Injections; Medroxyprogesterone Acetate; Norethindrone; Patient Compliance; Pregnancy; Pregnancy, Unplanned; Risk	2016
Copper containing intra-uterine devices versus depot progestogens for contraception. The Cochrane database of systematic reviews, 2010, Jun-16, Issue:6 Topics: Contraception; Contraceptive Agents, Female; Disease Progression; Female; HIV Infections; Humans; Intrauterine Devices, Copper; Medroxyprogesterone Acetate; Pregnancy; Progestins; Randomized Controlled Trials as Topic	2010
Copper intrauterine device vs. depot medroxyprogesterone acetate for contraception. American family physician, 2011, Jan-01, Volume: 83, Issue:1 Topics: Contraception; Contraceptive Agents, Female; Female; HIV Infections; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Medroxyprogesterone Acetate; Patient Compliance; Pregnancy; Randomized Controlled Trials as Topic	2011
Sexually transmitted infections and contraceptives: selective issues. Obstetrics and gynecology clinics of North America, 2003, Volume: 30, Issue:4 Topics: Chlamydia Infections; Condoms; Contraception; Contraceptive Devices, Female; Contraceptives, Oral; Female; Gonorrhea; HIV Infections; Humans; Intrauterine Devices; Male; Medroxyprogesterone Acetate; Papillomaviridae; Pelvic Inflammatory Disease; Sexually Transmitted Diseases	2003
Overview of why hormones may be an issue. Journal of acquired immune deficiency syndromes (1999), 2005, Volume: 38 Suppl 1 Topics: Animals; Contraceptives, Oral, Hormonal; Female; HIV Infections; Humans; Luteal Phase; Macaca mulatta; Medroxyprogesterone Acetate; Mice; Risk Factors; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Species Specificity	2005
Effect of exogenous hormones. Journal of acquired immune deficiency syndromes (1999), 2005, Volume: 38 Suppl 1 Topics: Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Drug Implants; Female; Genitalia, Female; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV-1; Humans; Medroxyprogesterone Acetate; Prospective Studies	2005

Trials

30 trial(s) available for medroxyprogesterone acetate and HIV Coinfection

Article	Year
Incidence of Herpes Simplex Virus Type 2 Infection Among African Women Using Depot Medroxyprogesterone Acetate, a Copper Intrauterine Device, or a Levonorgestrel Implant for Contraception: A Nested Randomized Trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022, 09-10, Volume: 75, Issue:4 Topics: Contraception; Contraceptive Agents, Female; Female; Herpes Simplex; Herpesvirus 2, Human; HIV Infections; Humans; Incidence; Intrauterine Devices, Copper; Levonorgestrel; Male; Medroxyprogesterone Acetate	2022
The Effect of Contraception on Genital Cytokines in Women Randomized to Copper Intrauterine Device, Depot Medroxyprogesterone Acetate, or Levonorgestrel Implant. The Journal of infectious diseases, 2022, 09-13, Volume: 226, Issue:5 Topics: Contraception; Contraceptive Agents, Female; Cytokines; Female; Genitalia; HIV Infections; Humans; Intrauterine Devices, Copper; Levonorgestrel; Medroxyprogesterone Acetate	2022
Genital inflammatory status and the innate immune response to contraceptive initiation. American journal of reproductive immunology (New York, N.Y. : 1989), 2022, Volume: 88, Issue:2 Topics: Contraceptive Agents, Female; Cytokines; Female; Genitalia; HIV Infections; Humans; Immunity, Innate; Inflammation; Intrauterine Devices, Copper; Levonorgestrel; Medroxyprogesterone Acetate	2022
Initiating Intramuscular Depot Medroxyprogesterone Acetate Increases Frequencies of Th17-like Human Immunodeficiency Virus Target Cells in the Genital Tract of Women in South Africa: A Randomized Trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022, 11-30, Volume: 75, Issue:11 Topics: Contraceptive Agents, Female; Copper; Disease Susceptibility; Female; HIV; HIV Infections; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Proteomics; South Africa; Vagina	2022
Post-randomization Differences in Condomless Vaginal Sex Among Women Randomized to Intramuscular Depot Medroxyprogesterone Acetate Injections, a Copper Intrauterine Device or a Levonorgestrel Implant in the ECHO Trial. AIDS and behavior, 2023, Volume: 27, Issue:3 Topics: Contraceptive Agents, Female; Female; HIV Infections; Humans; Intrauterine Devices, Copper; Levonorgestrel; Male; Medroxyprogesterone Acetate; Prostate-Specific Antigen; Random Allocation; South Africa; Unsafe Sex	2023
Use of reliable contraceptives and its correlates among women participating in Simulated HIV vaccine efficacy trials in key-populations in Uganda. Scientific reports, 2019, 10-28, Volume: 9, Issue:1 Topics: Adolescent; Adult; AIDS Vaccines; Contraception; Contraceptive Agents, Female; Female; HIV Infections; Humans; Medroxyprogesterone Acetate; Middle Aged; Prospective Studies; Sex Workers; Uganda	2019
Pharmacogenetics of interaction between depot medroxyprogesterone acetate and efavirenz, rifampicin, and isoniazid during treatment of HIV and tuberculosis. Pharmacogenetics and genomics, 2022, 01-01, Volume: 32, Issue:1 Topics: Anti-HIV Agents; Antitubercular Agents; Benzoxazines; Drug Interactions; Female; HIV Infections; Humans; Isoniazid; Medroxyprogesterone Acetate; Pharmacogenetics; Rifampin; Tuberculosis	2022
Contraceptive Use and Pregnancy Incidence Among Women Participating in an HIV Prevention Trial. Journal of women's health (2002), 2017, Volume: 26, Issue:6 Topics: Adolescent; Adult; Chemoprevention; Contraception; Contraception Behavior; Contraceptives, Oral, Combined; Female; HIV Infections; Humans; Incidence; Medroxyprogesterone Acetate; Middle Aged; Outcome Assessment, Health Care; Pregnancy; Proportional Hazards Models; Uganda; Young Adult	2017
Brief Report: Dapivirine Vaginal Ring Use Does Not Diminish the Effectiveness of Hormonal Contraception. Journal of acquired immune deficiency syndromes (1999), 2017, 10-01, Volume: 76, Issue:2 Topics: Adolescent; Adult; Anti-Retroviral Agents; Contraception; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Hormonal; Double-Blind Method; Drug Interactions; Female; Follow-Up Studies; HIV Infections; Humans; Incidence; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Pregnancy; Pyrimidines; Young Adult	2017
Effect of the depot medroxyprogesterone acetate injectable and levonorgestrel implant on HIV genital shedding: a randomized trial. Contraception, 2018, Volume: 98, Issue:3 Topics: Adult; Anti-Retroviral Agents; Contraceptive Agents, Female; Female; HIV; HIV Infections; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Vaginal Smears; Virus Shedding	2018
Effect of Hormonal Contraception on Pharmacokinetics of Vaginal Tenofovir in Healthy Women: Increased Tenofovir Diphosphate in Injectable Depot Medroxyprogesterone Acetate Users. Journal of acquired immune deficiency syndromes (1999), 2019, 01-01, Volume: 80, Issue:1 Topics: Administration, Intravaginal; Adult; Anti-HIV Agents; Contraceptive Agents, Female; Drug Interactions; Female; Healthy Volunteers; HIV Infections; Humans; Medroxyprogesterone Acetate; Menstrual Cycle; Middle Aged; Prospective Studies; Tenofovir; Treatment Outcome; Vaginal Creams, Foams, and Jellies; Young Adult	2019
Use of contraceptive depot medroxyprogesterone acetate is associated with impaired cervicovaginal mucosal integrity. The Journal of clinical investigation, 2018, 10-01, Volume: 128, Issue:10 Topics: Adult; Cervix Uteri; Contraceptive Agents, Female; Female; HIV Infections; HIV-1; Humans; Immunity, Mucosal; Medroxyprogesterone Acetate; Middle Aged; Mucous Membrane; Prospective Studies; Seroepidemiologic Studies; Vagina	2018
The Effect of Hormonal Contraception on Cervicovaginal Mucosal End Points Associated with HIV Acquisition. AIDS research and human retroviruses, 2019, Volume: 35, Issue:9 Topics: Adolescent; Adult; Cervix Uteri; Contraceptives, Oral; Cytokines; Disease Susceptibility; Female; HIV Infections; HIV-1; Hormonal Contraception; Humans; Injections; Medroxyprogesterone Acetate; Middle Aged; Mucous Membrane; Prospective Studies; Vagina; Young Adult	2019
Brief Report: HIV Shedding in the Female Genital Tract of Women on ART and Progestin Contraception: Extended Follow-up Results of a Randomized Clinical Trial. Journal of acquired immune deficiency syndromes (1999), 2019, 06-01, Volume: 81, Issue:2 Topics: Adult; Alkynes; Anti-Retroviral Agents; Benzoxazines; Cervix Uteri; Contraception; Contraceptive Agents, Female; Cyclopropanes; Drug Implants; Female; Follow-Up Studies; Genitalia, Female; HIV Infections; Humans; Levonorgestrel; Malawi; Medroxyprogesterone Acetate; Progestins; Treatment Outcome; Virus Shedding	2019
HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial. Lancet (London, England), 2019, 07-27, Volume: 394, Issue:10195 Topics: Adolescent; Adult; Eswatini; Family Planning Services; Female; HIV Infections; Humans; Incidence; Intention to Treat Analysis; Intrauterine Devices, Copper; Kenya; Levonorgestrel; Medroxyprogesterone Acetate; Pregnancy; South Africa; Young Adult; Zambia	2019
In the name of science: Ethical violations in the ECHO randomised trial. Global public health, 2022, Volume: 17, Issue:12 Topics: Africa; Contraceptive Agents, Female; Female; HIV Infections; Humans; Medroxyprogesterone Acetate	2022
Medroxyprogesterone acetate concentrations among HIV-infected depot-medroxyprogesterone acetate users receiving antiretroviral therapy in Lilongwe, Malawi. Contraception, 2019, Volume: 100, Issue:5 Topics: Adult; Anti-HIV Agents; Contraception; Contraceptive Agents, Female; Delayed-Action Preparations; Female; HIV Infections; Humans; Malawi; Medroxyprogesterone Acetate; Progestins; Treatment Outcome; Young Adult	2019
Contraceptive adherence among HIV-infected women in Malawi: a randomized controlled trial of the copper intrauterine device and depot medroxyprogesterone acetate. Contraception, 2013, Volume: 88, Issue:6 Topics: Adult; Contraception Behavior; Contraceptive Agents, Female; Female; HIV Infections; Humans; Intrauterine Devices, Copper; Malawi; Medroxyprogesterone Acetate; Patient Compliance	2013
Preference for Sayana® Press versus intramuscular Depo-Provera among HIV-positive women in Rakai, Uganda: a randomized crossover trial. Contraception, 2014, Volume: 89, Issue:5 Topics: Adolescent; Adult; Contraceptive Agents, Female; Cross-Over Studies; Female; HIV Infections; Humans; Injections, Intramuscular; Injections, Subcutaneous; Medroxyprogesterone Acetate; Middle Aged; Patient Preference; Uganda; Young Adult	2014
Preexposure prophylaxis is efficacious for HIV-1 prevention among women using depot medroxyprogesterone acetate for contraception. AIDS (London, England), 2014, Nov-28, Volume: 28, Issue:18 Topics: Adult; Anti-Retroviral Agents; Contraceptive Agents, Female; Delayed-Action Preparations; Female; HIV Infections; Humans; Kenya; Male; Medroxyprogesterone Acetate; Pre-Exposure Prophylaxis; Pregnancy; Randomized Controlled Trials as Topic; Treatment Outcome; Uganda	2014
Depot medroxyprogesterone acetate in combination with a twice-daily lopinavir-ritonavir-based regimen in HIV-infected women showed effective contraception and a lack of clinically significant interactions, with good safety and tolerability: results of the Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:4 Topics: Adolescent; Contraceptives, Oral, Synthetic; Delayed-Action Preparations; Drug Interactions; Female; HIV Infections; HIV Protease Inhibitors; Humans; Lopinavir; Medroxyprogesterone Acetate; Middle Aged; Ovulation; Progesterone; Ritonavir; Young Adult	2015
Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study. The lancet. HIV, 2015, Volume: 2, Issue:7 Topics: Adult; Cohort Studies; Contraception Behavior; Contraceptive Agents, Female; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Incidence; Medroxyprogesterone Acetate; Norethindrone; Proportional Hazards Models; Risk Factors; South Africa; Tenofovir; Young Adult	2015
Effect of Depot Medoxyprogesterone Acetate on Immune Functions and Inflammatory Markers of HIV-Infected Women. Journal of acquired immune deficiency syndromes (1999), 2016, Feb-01, Volume: 71, Issue:2 Topics: Adolescent; Adult; Biomarkers; Contraceptive Agents, Female; Delayed-Action Preparations; Female; HIV Infections; Humans; Immunity, Cellular; Inflammation; Injections, Intramuscular; Lymphocyte Activation; Medroxyprogesterone Acetate; Middle Aged; T-Lymphocytes, Regulatory; Young Adult	2016
Medroxyprogesterone acetate levels among Kenyan women using depot medroxyprogesterone acetate in the FEM-PrEP trial. Contraception, 2016, Volume: 94, Issue:1 Topics: Adolescent; Adult; Contraceptive Agents, Female; Delayed-Action Preparations; Drug Interactions; Emtricitabine; Female; HIV Infections; Humans; Kenya; Medroxyprogesterone Acetate; Pre-Exposure Prophylaxis; Pregnancy; Pregnancy Tests; Tenofovir; Young Adult	2016
A randomized clinical trial on the effects of progestin contraception in the genital tract of HIV-infected and uninfected women in Lilongwe, Malawi: Addressing evolving research priorities. Contemporary clinical trials, 2017, Volume: 52 Topics: Anti-HIV Agents; Case-Control Studies; Cervix Uteri; Contraceptive Agents, Female; Delayed-Action Preparations; Drug Implants; Female; HIV Infections; Humans; Levonorgestrel; Malawi; Medroxyprogesterone Acetate; Mucous Membrane; Pilot Projects; Research; Treatment Outcome; Vagina; Virus Shedding	2017
Prospective clinical trials designed to assess the use of hormonal contraceptives and risk of HIV acquisition. Journal of acquired immune deficiency syndromes (1999), 2005, Volume: 38 Suppl 1 Topics: Adolescent; Adult; Cohort Studies; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Drug Implants; Female; HIV Infections; Humans; Medroxyprogesterone Acetate; Prospective Studies; Risk Factors; Thailand; Uganda; Zimbabwe	2005
Prospective study of hormonal contraception and women's risk of HIV infection in South Africa. International journal of epidemiology, 2007, Volume: 36, Issue:1 Topics: Adult; Age Distribution; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Female; HIV Infections; Humans; Incidence; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Prospective Studies; Risk Factors; Sexual Behavior; Sexually Transmitted Diseases; South Africa; Time Factors; Uterine Cervical Neoplasms	2007
Depo-medroxyprogesterone in women on antiretroviral therapy: effective contraception and lack of clinically significant interactions. Clinical pharmacology and therapeutics, 2007, Volume: 81, Issue:2 Topics: Adult; Alkynes; Antiretroviral Therapy, Highly Active; Area Under Curve; Benzoxazines; CD4 Lymphocyte Count; Chromatography, Liquid; Cyclopropanes; Drug Administration Schedule; Drug Interactions; Female; Half-Life; HIV Infections; HIV Protease Inhibitors; Humans; Injections; Medroxyprogesterone Acetate; Middle Aged; Nelfinavir; Nevirapine; Ovulation Inhibition; Oxazines; Progesterone; Reverse Transcriptase Inhibitors; RNA, Viral; Time Factors	2007
Pharmacokinetic interactions between depot medroxyprogesterone acetate and combination antiretroviral therapy. Fertility and sterility, 2008, Volume: 90, Issue:4 Topics: Adult; Anti-Retroviral Agents; Contraceptives, Oral, Synthetic; Delayed-Action Preparations; Drug Interactions; Drug Therapy, Combination; Female; HIV Infections; Humans; Medroxyprogesterone Acetate	2008
Safety and tolerability of depot medroxyprogesterone acetate among HIV-infected women on antiretroviral therapy: ACTG A5093. Contraception, 2008, Volume: 77, Issue:2 Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Contraceptive Agents, Female; Cyclopropanes; Drug Interactions; Female; HIV Infections; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Nelfinavir; Nevirapine; Ovulation Inhibition; RNA, Viral; Safety; Viral Load	2008

Other Studies

99 other study(ies) available for medroxyprogesterone acetate and HIV Coinfection

Article	Year
Sexually transmitted infections and depot medroxyprogesterone acetate do not impact protection from simian HIV acquisition by long-acting cabotegravir in macaques. AIDS (London, England), 2022, 02-01, Volume: 36, Issue:2 Topics: Animals; Diketopiperazines; Female; HIV Infections; Humans; Macaca; Medroxyprogesterone Acetate; Pyridones; Sexually Transmitted Diseases; Simian Acquired Immunodeficiency Syndrome	2022
The Progestin Medroxyprogesterone Acetate Affects HIV-1 Production in Human Lymphoid Tissue Explants in a Dose-Dependent and Glucocorticoid-like Fashion. Viruses, 2021, 11-18, Volume: 13, Issue:11 Topics: Child; Contraceptive Agents, Hormonal; Female; HIV Infections; HIV-1; Humans; Lymphoid Tissue; Male; Medroxyprogesterone Acetate; Virus Replication	2021
Intramuscular depot medroxyprogesterone acetate accentuates bone loss associated with tenofovir disoproxil fumarate-containing antiretroviral therapy initiation in young women living with HIV (the BONE: CARE study): a prospective cohort study in Uganda. The Lancet. Global health, 2022, Volume: 10, Issue:5 Topics: Adult; Bone Density; Contraceptive Agents, Female; Female; HIV Infections; Humans; Male; Medroxyprogesterone Acetate; Prospective Studies; Tenofovir; Uganda; Young Adult	2022
Multi-omics analysis of the cervical epithelial integrity of women using depot medroxyprogesterone acetate. PLoS pathogens, 2022, Volume: 18, Issue:5 Topics: Cervix Uteri; Contraceptive Agents, Female; Female; HIV Infections; Humans; Kenya; Medroxyprogesterone Acetate; Serpins	2022
Increased HIV-1 infection in PBMCs treated in vitro with menstrual cycle phase hormones or medroxyprogesterone acetate likely occurs via different mechanisms. American journal of reproductive immunology (New York, N.Y. : 1989), 2022, Volume: 88, Issue:6 Topics: Contraceptive Agents, Female; Female; HIV Infections; HIV-1; Humans; Leukocytes, Mononuclear; Medroxyprogesterone Acetate; Menstrual Cycle; Progesterone; Receptors, Glucocorticoid	2022
Interaction of Depot Medroxyprogesterone Acetate and Tenofovir Disoproxil Fumarate/Emtricitabine on Peripheral Blood Mononuclear Cells and Cervical Tissue Susceptibility to HIV Infection and Pharmacokinetics. Journal of acquired immune deficiency syndromes (1999), 2023, 01-01, Volume: 92, Issue:1 Topics: Emtricitabine; Female; HIV Infections; Humans; Leukocytes, Mononuclear; Medroxyprogesterone Acetate; Tenofovir	2023
Vaginal microbiome, antiretroviral concentrations, and HIV genital shedding in the setting of hormonal contraception initiation in Malawi. AIDS (London, England), 2023, 11-15, Volume: 37, Issue:14 Topics: Anti-Retroviral Agents; Female; HIV Infections; Hormonal Contraception; Humans; Lamivudine; Levonorgestrel; Malawi; Medroxyprogesterone Acetate; Microbiota; Tenofovir; Vagina	2023
Pharmacokinetics and Pharmacodynamics of Depot Medroxyprogesterone Acetate in African Women Receiving Treatment for Human Immunodeficiency Virus and Tuberculosis: Potential Concern for Standard Dosing Frequency. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020, 07-27, Volume: 71, Issue:3 Topics: Adult; Africa; Contraceptive Agents, Female; Delayed-Action Preparations; Female; HIV; HIV Infections; Humans; Medroxyprogesterone Acetate; Pregnancy; Reference Standards; Tuberculosis	2020
What impact could DMPA use have had in South Africa and how might its continued use affect the future of the HIV epidemic? Journal of the International AIDS Society, 2019, Volume: 22, Issue:11 Topics: Adult; Contraception Behavior; Contraceptive Agents, Female; Epidemics; Female; Heterosexuality; HIV Infections; Humans; Male; Medroxyprogesterone Acetate; Risk Factors; Sexual Partners; South Africa	2019
Exploring the immunomodulatory role of depot medroxyprogesterones acetate and endogenous progesterone levels in HIV infected and uninfected women. BMC research notes, 2019, Nov-15, Volume: 12, Issue:1 Topics: Adult; Chemokine CCL3; Chemokine CCL4; Chemokine CCL5; Contraceptive Agents, Female; Contraceptive Agents, Hormonal; Cross-Sectional Studies; Female; Gene Expression Regulation; HIV Infections; HIV-1; Humans; Immunomodulation; Medroxyprogesterone Acetate; Progesterone; Proof of Concept Study; Receptors, CCR5; Receptors, CXCR4	2019
Is the Injectable Contraceptive Depo-Medroxyprogesterone Acetate (DMPA-IM) Associated with an Increased Risk for HIV Acquisition? The Jury Is Still Out. AIDS research and human retroviruses, 2020, Volume: 36, Issue:5 Topics: Adult; Contraception; Contraceptive Agents, Female; Female; HIV Infections; Humans; Injections, Intramuscular; Male; Medroxyprogesterone Acetate; Randomized Controlled Trials as Topic; Risk Factors	2020
ECHO: context and limitations. Lancet (London, England), 2020, 02-08, Volume: 395, Issue:10222 Topics: Contraception; Female; HIV Infections; Humans; Incidence; Intrauterine Devices, Copper; Levonorgestrel; Medroxyprogesterone Acetate	2020
ECHO: context and limitations. Lancet (London, England), 2020, 02-08, Volume: 395, Issue:10222 Topics: Contraception; Female; HIV Infections; Humans; Incidence; Intrauterine Devices, Copper; Levonorgestrel; Medroxyprogesterone Acetate	2020
ECHO: context and limitations. Lancet (London, England), 2020, 02-08, Volume: 395, Issue:10222 Topics: Contraception; Female; HIV Infections; Humans; Incidence; Intrauterine Devices, Copper; Levonorgestrel; Medroxyprogesterone Acetate	2020
ECHO: context and limitations. Lancet (London, England), 2020, 02-08, Volume: 395, Issue:10222 Topics: Contraception; Female; HIV Infections; Humans; Incidence; Intrauterine Devices, Copper; Levonorgestrel; Medroxyprogesterone Acetate	2020
ECHO: context and limitations. Lancet (London, England), 2020, 02-08, Volume: 395, Issue:10222 Topics: Contraception; Female; HIV Infections; Humans; Incidence; Intrauterine Devices, Copper; Levonorgestrel; Medroxyprogesterone Acetate	2020
Norethisterone Enanthate Increases Mouse Susceptibility to Genital Infection with Herpes Simplex Virus Type 2 and HIV Type 1. ImmunoHorizons, 2020, 02-11, Volume: 4, Issue:2 Topics: Animals; Contraceptive Agents, Female; Desmoglein 1; Disease Susceptibility; Female; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV-1; Medroxyprogesterone Acetate; Mice; Mice, Inbred C57BL; Mice, SCID; Mucous Membrane; Norethindrone; Permeability; Vagina	2020
HIV, progestins, genital epithelial barrier function, and the burden of objectivity†. Biology of reproduction, 2020, 08-04, Volume: 103, Issue:2 Topics: Adult; Contraception; Contraceptive Agents, Female; Epithelium; Female; Genitalia; HIV Infections; Humans; Medroxyprogesterone Acetate	2020
Pharmacokinetic and Pharmacodynamic Impacts of Depot Medroxyprogesterone Acetate Use on HIV Pre-exposure Prophylaxis in Women. Journal of acquired immune deficiency syndromes (1999), 2020, 10-01, Volume: 85, Issue:2 Topics: Adolescent; Adult; Anti-HIV Agents; Emtricitabine; Female; HIV Infections; Humans; Leukocytes, Mononuclear; Medroxyprogesterone Acetate; Middle Aged; Pilot Projects; Pre-Exposure Prophylaxis; Tenofovir; Young Adult	2020
Regular Use of Depot Medroxyprogesterone Acetate Causes Thinning of the Superficial Lining and Apical Distribution of Human Immunodeficiency Virus Target Cells in the Human Ectocervix. The Journal of infectious diseases, 2022, 04-01, Volume: 225, Issue:7 Topics: Cervix Uteri; Contraceptive Agents, Female; Female; HIV; HIV Infections; Humans; Medroxyprogesterone Acetate	2022
Responding to the ECHO trial results: modelling the potential impact of changing contraceptive method mix on HIV and reproductive health in South Africa. Journal of the International AIDS Society, 2020, Volume: 23, Issue:10 Topics: Adult; Contraception; Contraception Behavior; Contraceptive Agents, Female; Female; HIV Infections; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Randomized Controlled Trials as Topic; Reproductive Health; Risk Factors; South Africa	2020
Transcriptional response of vaginal epithelial cells to medroxyprogesterone acetate treatment results in decreased barrier integrity. Journal of reproductive immunology, 2021, Volume: 143 Topics: Cell Line; Cell Membrane Permeability; Contraceptive Agents, Female; Disease Susceptibility; Epithelial Cells; Estradiol; Female; Gene Expression Profiling; HIV Infections; HIV-1; Humans; Medroxyprogesterone Acetate; Progesterone; Transcription, Genetic; Transcriptome; Vagina	2021
A Semimechanistic Pharmacokinetic Model for Depot Medroxyprogesterone Acetate and Drug-Drug Interactions With Antiretroviral and Antituberculosis Treatment. Clinical pharmacology and therapeutics, 2021, Volume: 110, Issue:4 Topics: Alkynes; Anti-Retroviral Agents; Antitubercular Agents; Benzoxazines; Contraceptive Agents, Hormonal; Contraceptive Effectiveness; Cyclopropanes; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inducers; Cytochrome P-450 CYP3A Inhibitors; Delayed-Action Preparations; Drug Administration Schedule; Drug Combinations; Drug Interactions; Female; HIV Infections; Humans; Isoniazid; Lopinavir; Medroxyprogesterone Acetate; Nelfinavir; Rifampin; Ritonavir; Tuberculosis	2021
Medroxyprogesterone acetate-treated human, primary endometrial epithelial cells reveal unique gene expression signature linked to innate immunity and HIV-1 susceptibility. American journal of reproductive immunology (New York, N.Y. : 1989), 2018, Volume: 79, Issue:1 Topics: Adult; Cells, Cultured; Cholesterol; Contraceptive Agents, Female; Disease Susceptibility; Epithelial Cells; Female; Genitalia, Female; HIV Infections; HIV-1; Humans; Immunity, Innate; Inflammation; Medroxyprogesterone Acetate; Middle Aged; Mucous Membrane; Primary Cell Culture; Progesterone; Progestins; Tissue Array Analysis; Transcriptome	2018
Is a lower-dose, subcutaneous contraceptive injectable containing depot medroxyprogesterone acetate likely to impact women's risk of HIV? Contraception, 2018, Volume: 97, Issue:3 Topics: Adolescent; Adult; Africa South of the Sahara; Contraception; Contraceptive Agents, Female; Delayed-Action Preparations; Female; HIV; HIV Infections; Humans; Injections, Subcutaneous; Medroxyprogesterone Acetate; Risk Factors; Young Adult	2018
Exogenous oestrogen inhibits genital transmission of cell-associated HIV-1 in DMPA-treated humanized mice. Journal of the International AIDS Society, 2018, Volume: 21, Issue:1 Topics: Animals; Estrogens; Female; HIV Infections; HIV-1; Humans; Medroxyprogesterone Acetate; Mice; Mice, Inbred NOD; Vagina	2018
A Longitudinal Assessment of Cervical Inflammation and Immunity Associated with HIV-1 Infection, Hormonal Contraception, and Pregnancy. AIDS research and human retroviruses, 2018, Volume: 34, Issue:10 Topics: Adolescent; Adult; Biomarkers; Cervix Uteri; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Female; HIV Infections; Humans; Inflammation Mediators; Longitudinal Studies; Medroxyprogesterone Acetate; Pregnancy; Seroconversion; Uganda; Vaginal Smears; Young Adult; Zimbabwe	2018
Progestin-based contraception regimens modulate expression of putative HIV risk factors in the vaginal epithelium of pig-tailed Macaques. American journal of reproductive immunology (New York, N.Y. : 1989), 2018, Volume: 80, Issue:4 Topics: Animals; Contraception; Contraceptive Agents, Female; Ethinyl Estradiol; Female; HIV Infections; Interleukin-10; Levonorgestrel; Macaca nemestrina; Medroxyprogesterone Acetate; Mucous Membrane; Progestins; Risk Factors; Vagina	2018
Changes to the World Health Organization guideline on hormonal contraceptive eligibility for women at high risk of HIV: South African perspective and response. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2018, Jul-25, Volume: 108, Issue:8 Topics: Contraceptive Agents, Female; Female; HIV Infections; Humans; Injections; Medroxyprogesterone Acetate; Patient Selection; Practice Guidelines as Topic; Progestins; Risk Assessment; South Africa; World Health Organization	2018
The Need for Policy Change Regarding Progestin-Only Injectable Contraceptives. Journal of women's health (2002), 2019, Volume: 28, Issue:9 Topics: Contraceptive Agents, Hormonal; Female; Health Policy; HIV Infections; Humans; Medroxyprogesterone Acetate; Progestins; Risk Factors	2019
Pharmacokinetic, biologic and epidemiologic differences in MPA- and NET-based progestin-only injectable contraceptives relative to the potential impact on HIV acquisition in women. Contraception, 2019, Volume: 99, Issue:4 Topics: Contraceptive Agents, Hormonal; Disease Susceptibility; Female; HIV Infections; Humans; Medroxyprogesterone Acetate; Norethindrone	2019
Increased Cervical CD4 AIDS research and human retroviruses, 2019, Volume: 35, Issue:3 Topics: Adult; CD4-Positive T-Lymphocytes; Cervix Uteri; Cohort Studies; Contraceptive Agents, Female; Cross-Sectional Studies; Cytokines; Disease Susceptibility; Female; HIV Infections; Humans; Kenya; Lymphocyte Activation; Medroxyprogesterone Acetate; Receptors, CCR5; Sex Workers	2019
HIV risk associated with serum medroxyprogesterone acetate levels among women in East and southern Africa. AIDS (London, England), 2019, 03-15, Volume: 33, Issue:4 Topics: Adult; Africa, Eastern; Africa, Southern; Case-Control Studies; Contraceptive Agents, Hormonal; Diagnostic Tests, Routine; Female; HIV Infections; Humans; Longitudinal Studies; Male; Medroxyprogesterone Acetate; Risk Assessment; Serum	2019
Effects of three long-acting reversible contraceptive methods on HIV target cells in the human uterine cervix and peripheral blood. Reproductive biology and endocrinology : RB&E, 2019, Feb-22, Volume: 17, Issue:1 Topics: Adult; Cervix Uteri; Contraception; Contraceptive Agents, Female; Desogestrel; Female; HIV; HIV Infections; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Receptors, CCR5; Receptors, CXCR4; T-Lymphocytes; Young Adult	2019
The contraceptive medroxyprogesterone acetate, unlike norethisterone, directly increases R5 HIV-1 infection in human cervical explant tissue at physiologically relevant concentrations. Scientific reports, 2019, 03-13, Volume: 9, Issue:1 Topics: Cervix Uteri; Contraceptive Agents, Hormonal; Dose-Response Relationship, Drug; Female; HEK293 Cells; HIV Infections; HIV-1; Humans; In Vitro Techniques; Medroxyprogesterone Acetate; Norethindrone; Receptors, CCR5; Risk Factors; RNA, Messenger; Virus Replication	2019
Association of endogenous progesterone levels in young women using hormonal contraception with recent HIV-1 infection. BMC women's health, 2019, 05-08, Volume: 19, Issue:1 Topics: Adult; Contraception; Contraceptive Agents, Female; Cross-Sectional Studies; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Incidence; Medroxyprogesterone Acetate; Pilot Projects; Progesterone; South Africa; Young Adult	2019
Cervical and systemic concentrations of long acting hormonal contraceptive (LARC) progestins depend on delivery method: Implications for the study of HIV transmission. PloS one, 2019, Volume: 14, Issue:5 Topics: Adolescent; Adult; Cervix Uteri; Contraception; Contraceptive Agents, Female; Desogestrel; Female; HIV Infections; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Progestins; Young Adult	2019
Depot Medroxyprogesterone Acetate and the Vaginal Microbiome as Modifiers of Tenofovir Diphosphate and Lamivudine Triphosphate Concentrations in the Female Genital Tract of Ugandan Women: Implications for Tenofovir Disoproxil Fumarate/Lamivudine in Preexp Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020, 04-10, Volume: 70, Issue:8 Topics: Adenine; Anti-HIV Agents; Cytidine Triphosphate; Dideoxynucleotides; Emtricitabine; Female; HIV Infections; Humans; Lamivudine; Medroxyprogesterone Acetate; Microbiota; Organophosphates; Pre-Exposure Prophylaxis; Tenofovir; Uganda	2020
Immunosuppressive biological mechanisms support reassessment of use of the injectable contraceptive medroxyprogesterone acetate. Endocrinology, 2013, Volume: 154, Issue:3 Topics: Contraceptive Agents, Female; Female; HIV Infections; HIV-1; Humans; Immune Tolerance; Immunosuppressive Agents; Injections, Intramuscular; Medroxyprogesterone Acetate; Models, Immunological; Risk Factors	2013
Hormonal contraceptive use and discontinuation among HIV-infected women in Uganda and Zimbabwe. Journal of acquired immune deficiency syndromes (1999), 2013, Aug-01, Volume: 63, Issue:4 Topics: Adult; Antiretroviral Therapy, Highly Active; Contraception Behavior; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Delayed-Action Preparations; Female; HIV Infections; Humans; Injections, Intramuscular; Interpersonal Relations; Kaplan-Meier Estimate; Medroxyprogesterone Acetate; Multivariate Analysis; Nausea; Proportional Hazards Models; Prospective Studies; Reproductive Tract Infections; Sweating; Time Factors; Uganda; Young Adult; Zimbabwe	2013
Next steps for research on hormonal contraception and HIV. Lancet (London, England), 2013, Nov-02, Volume: 382, Issue:9903 Topics: Contraception; Contraceptive Agents, Female; Female; HIV Infections; Humans; Medroxyprogesterone Acetate; Norethindrone; Randomized Controlled Trials as Topic; Risk Assessment	2013
Effects of hormonal contraceptive use on HIV acquisition and transmission among HIV-discordant couples. AIDS (London, England), 2013, Volume: 27 Suppl 1 Topics: Adolescent; Adult; Cohort Studies; Contraceptive Agents, Female; Contraceptives, Oral; Family Characteristics; Female; HIV Infections; Humans; Incidence; Levonorgestrel; Male; Medroxyprogesterone Acetate; Middle Aged; Retrospective Studies; Risk Assessment; Uganda; Young Adult	2013
Research on hormonal contraception and HIV. Lancet (London, England), 2014, Jan-25, Volume: 383, Issue:9914 Topics: Contraceptive Agents, Female; Female; HIV Infections; Humans; Medroxyprogesterone Acetate; Norethindrone; Randomized Controlled Trials as Topic	2014
Research on hormonal contraception and HIV. Lancet (London, England), 2014, Jan-25, Volume: 383, Issue:9914 Topics: Contraceptive Agents, Female; Female; HIV Infections; Humans; Medroxyprogesterone Acetate; Norethindrone; Randomized Controlled Trials as Topic	2014
Research on hormonal contraception and HIV. Lancet (London, England), 2014, Jan-25, Volume: 383, Issue:9914 Topics: Contraceptive Agents, Female; Female; HIV Infections; Humans; Medroxyprogesterone Acetate; Norethindrone; Randomized Controlled Trials as Topic	2014
Research on hormonal contraception and HIV - Authors' reply. Lancet (London, England), 2014, Jan-25, Volume: 383, Issue:9914 Topics: Contraceptive Agents, Female; Female; HIV Infections; Humans; Medroxyprogesterone Acetate; Norethindrone; Randomized Controlled Trials as Topic	2014
Long-term effect of depot medroxyprogesterone acetate on vaginal microbiota, epithelial thickness and HIV target cells. The Journal of infectious diseases, 2014, Aug-15, Volume: 210, Issue:4 Topics: Adolescent; Adult; Antineoplastic Agents, Hormonal; Drug Implants; Epithelium; Female; HIV Infections; HIV-1; Humans; Medroxyprogesterone Acetate; Microbiota; Mucous Membrane; Vagina; Young Adult	2014
Non-human primate models of hormonal contraception and HIV. American journal of reproductive immunology (New York, N.Y. : 1989), 2014, Volume: 71, Issue:6 Topics: Animals; Contraceptives, Oral, Hormonal; Estradiol; Female; HIV Infections; HIV-1; Humans; Macaca; Medroxyprogesterone Acetate; Models, Animal; Progesterone; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Vagina	2014
A prospective cohort study of the effect of depot medroxyprogesterone acetate on detection of plasma and cervical HIV-1 in women initiating and continuing antiretroviral therapy. Journal of acquired immune deficiency syndromes (1999), 2014, Aug-01, Volume: 66, Issue:4 Topics: Adult; Anti-HIV Agents; Cervix Mucus; Cohort Studies; Cross-Sectional Studies; Delayed-Action Preparations; Female; HIV Infections; HIV-1; Humans; Kenya; Medroxyprogesterone Acetate; RNA, Viral	2014
Highlights from the 21st CROI. The Lancet. Infectious diseases, 2014, Volume: 14, Issue:4 Topics: Animals; Anti-HIV Agents; Child; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Hepatitis C; HIV Infections; Humans; Infant, Newborn; Male; Medication Adherence; Medroxyprogesterone Acetate; Norethindrone	2014
Sex hormones selectively impact the endocervical mucosal microenvironment: implications for HIV transmission. PloS one, 2014, Volume: 9, Issue:5 Topics: Animals; CD4-Positive T-Lymphocytes; Cervix Uteri; Chemokine CCL21; Chemokine CCL4; Endometrium; Estradiol; Estrogens; Female; Gene Expression; HIV Infections; Integrin alpha4; Integrin beta Chains; Macaca mulatta; Medroxyprogesterone Acetate; Mucins; Mucous Membrane; Receptors, CCR5	2014
Time to focus on improving the contraceptive method mix in high HIV prevalence settings and let go of unanswerable questions. Contraception, 2014, Volume: 90, Issue:4 Topics: Contraception; Contraceptive Agents, Female; Female; HIV Infections; Humans; Maternal Mortality; Medroxyprogesterone Acetate; Observational Studies as Topic; Pregnancy; Prevalence; Randomized Controlled Trials as Topic	2014
DMPA and HIV: do we need a trial? Contraception, 2014, Volume: 90, Issue:4 Topics: Clinical Trials as Topic; Contraceptive Agents, Female; Female; HIV Infections; Humans; Medroxyprogesterone Acetate; Risk Factors	2014
DMPA and HIV: why we need a trial. Contraception, 2014, Volume: 90, Issue:4 Topics: Contraceptive Agents, Female; Female; HIV Infections; Humans; Medroxyprogesterone Acetate; Pregnancy; Randomized Controlled Trials as Topic	2014
Depot-medroxyprogesterone acetate does not reduce the prophylactic efficacy of emtricitabine and tenofovir disoproxil fumarate in macaques. Journal of acquired immune deficiency syndromes (1999), 2014, Dec-01, Volume: 67, Issue:4 Topics: Adenine; Animals; Anti-HIV Agents; Contraceptive Agents, Female; Delayed-Action Preparations; Deoxycytidine; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Emtricitabine; Female; HIV Infections; Macaca nemestrina; Medroxyprogesterone Acetate; Phosphorous Acids; Pre-Exposure Prophylaxis; Treatment Outcome	2014
Hypothesis: amenorrhea-inducing contraception may reduce HIV acquisition risk. Contraception, 2014, Volume: 90, Issue:6 Topics: Contraceptive Agents, Female; Female; HIV Infections; Humans; Medroxyprogesterone Acetate; Pregnancy; Randomized Controlled Trials as Topic	2014
Tenofovir disoproxil fumarate intravaginal ring protects high-dose depot medroxyprogesterone acetate-treated macaques from multiple SHIV exposures. Journal of acquired immune deficiency syndromes (1999), 2015, Jan-01, Volume: 68, Issue:1 Topics: Adenine; Animals; Anti-HIV Agents; Delayed-Action Preparations; Female; HIV Infections; Macaca nemestrina; Medroxyprogesterone Acetate; Phosphorous Acids; Placebos; Simian Acquired Immunodeficiency Syndrome; Vagina	2015
Medroxyprogesterone Acetate Regulates HIV-1 Uptake and Transcytosis but Not Replication in Primary Genital Epithelial Cells, Resulting in Enhanced T-Cell Infection. The Journal of infectious diseases, 2015, Jun-01, Volume: 211, Issue:11 Topics: Cells, Cultured; Contraceptive Agents, Female; Cytokines; Endocytosis; Epithelial Cells; Female; HIV Infections; HIV-1; Humans; Medroxyprogesterone Acetate; Progesterone; T-Lymphocytes; Up-Regulation; Uterus; Virus Internalization; Virus Replication	2015
Mx2 expression is associated with reduced susceptibility to HIV infection in highly exposed HIV seronegative Kenyan sex workers. AIDS (London, England), 2015, Jan-02, Volume: 29, Issue:1 Topics: Adult; Disease Susceptibility; Female; HIV Infections; HIV Seronegativity; HIV-1; Humans; Immunity, Innate; Kenya; Leukocytes, Mononuclear; Medroxyprogesterone Acetate; Myxovirus Resistance Proteins; Proteomics; Sex Workers	2015
Study supports link between injectable hormonal contraceptive and HIV risk. BMJ (Clinical research ed.), 2015, Jan-09, Volume: 350 Topics: Contraceptive Agents, Female; Female; HIV Infections; Humans; Medroxyprogesterone Acetate	2015
Broadening the debate over HIV and hormonal contraception. The Lancet. Infectious diseases, 2015, Volume: 15, Issue:2 Topics: Contraceptive Agents, Female; Female; HIV Infections; Humans; Medroxyprogesterone Acetate	2015
End of the debate on hormonal contraception and HIV risk? The Lancet. Infectious diseases, 2015, Volume: 15, Issue:2 Topics: Contraceptive Agents, Female; Female; HIV Infections; Humans; Medroxyprogesterone Acetate	2015
Hormonal Contraception and Risk of Psychiatric and Other Noncommunicable Diseases in HIV-Infected Women. Journal of women's health (2002), 2015, Volume: 24, Issue:6 Topics: Adult; Cohort Studies; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Female; HIV Infections; Humans; Incidence; Medroxyprogesterone Acetate; Mental Disorders; Middle Aged; Retrospective Studies; Risk; Sexually Transmitted Diseases; Tennessee; Young Adult	2015
Human rights and clinical ethics are the right framework to address the probable DMPA-HIV interaction: authors' response. The journal of family planning and reproductive health care, 2015, Volume: 41, Issue:2 Topics: Contraception; Ethics, Clinical; HIV Infections; Human Rights; Humans; Medroxyprogesterone Acetate	2015
Molecular mechanisms linking high dose medroxyprogesterone with HIV-1 risk. PloS one, 2015, Volume: 10, Issue:3 Topics: Cell Line; Cell Proliferation; Contraceptive Agents, Female; Cytokines; Epithelial Cells; Female; Gene Expression Regulation; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Jurkat Cells; Medroxyprogesterone Acetate; Risk Factors; Up-Regulation; Vagina	2015
The effect of menopause on the innate antiviral activity of cervicovaginal lavage. American journal of obstetrics and gynecology, 2015, Volume: 213, Issue:2 Topics: Adult; Cervix Uteri; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Disease Susceptibility; Female; Herpes Simplex; Herpesvirus 1, Human; Herpesvirus 2, Human; HIV Infections; HIV-1; Humans; Immunity, Innate; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Menstrual Cycle; Middle Aged; Postmenopause; Premenopause; Vagina; Vaginal Douching; Viral Plaque Assay; Young Adult	2015
Two recent studies find Depo-Provera use increases HIV risk. AIDS (London, England), 2015, Jun-01, Volume: 29, Issue:9 Topics: Africa South of the Sahara; Contraceptive Agents, Female; Female; HIV Infections; Humans; Incidence; Medroxyprogesterone Acetate; Pregnancy; Risk Assessment	2015
Associations of hormonal contraceptive use with measures of HIV disease progression and antiretroviral therapy effectiveness. Contraception, 2016, Volume: 93, Issue:1 Topics: Adolescent; Adult; Anti-Retroviral Agents; CD4 Lymphocyte Count; Condoms; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Delayed-Action Preparations; Disease Progression; Drug Interactions; Female; HIV Infections; Humans; Injections, Intramuscular; Intrauterine Devices; Medroxyprogesterone Acetate; Middle Aged; Prospective Studies; Young Adult	2016
Injectable Progestin-Only Contraception is Associated With Increased Levels of Pro-Inflammatory Cytokines in the Female Genital Tract. American journal of reproductive immunology (New York, N.Y. : 1989), 2015, Volume: 74, Issue:4 Topics: Adolescent; Adult; Contraception; Contraceptive Agents, Female; Cross-Sectional Studies; Cytokines; Female; Genitalia, Female; HIV Infections; Humans; Inflammation; Kenya; Medroxyprogesterone Acetate; Norethindrone; Pregnancy; Progestins; Sexually Transmitted Diseases, Bacterial; South Africa; Vaginosis, Bacterial; Young Adult	2015
DMPA use and HIV acquisition: time to switch to NET-EN? The lancet. HIV, 2015, Volume: 2, Issue:7 Topics: Contraception Behavior; Contraceptive Agents, Female; Female; HIV Infections; HIV-1; Humans; Medroxyprogesterone Acetate; Norethindrone	2015
Interpretation, communication, and mechanisms of associations between injectable contraception and HIV risk. The lancet. HIV, 2015, Volume: 2, Issue:9 Topics: Contraception Behavior; Contraceptive Agents, Female; Female; HIV Infections; HIV-1; Humans; Medroxyprogesterone Acetate; Norethindrone	2015
Interpretation, communication, and mechanisms of associations between injectable contraception and HIV risk. The lancet. HIV, 2015, Volume: 2, Issue:9 Topics: Contraception Behavior; Contraceptive Agents, Female; Female; HIV Infections; HIV-1; Humans; Medroxyprogesterone Acetate; Norethindrone	2015
Interpretation, communication, and mechanisms of associations between injectable contraception and HIV risk - Authors' reply. The lancet. HIV, 2015, Volume: 2, Issue:9 Topics: Contraception Behavior; Contraceptive Agents, Female; Female; HIV Infections; HIV-1; Humans; Medroxyprogesterone Acetate; Norethindrone	2015
Interpretation, communication, and mechanisms of associations between injectable contraception and HIV risk. The lancet. HIV, 2015, Volume: 2, Issue:9 Topics: Contraception Behavior; Contraceptive Agents, Female; Female; HIV Infections; HIV-1; Humans; Medroxyprogesterone Acetate; Norethindrone	2015
Interpretation, communication, and mechanisms of associations between injectable contraception and HIV risk - Authors' reply. The lancet. HIV, 2015, Volume: 2, Issue:9 Topics: Contraception Behavior; Contraceptive Agents, Female; Female; HIV Infections; HIV-1; Humans; Medroxyprogesterone Acetate; Norethindrone	2015
[Dual contraception adherence among HIV-infected women]. Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia, 2015, Volume: 37, Issue:10 Topics: Adolescent; Adult; Condoms; Contraceptive Agents, Female; Cross-Sectional Studies; Female; HIV Infections; Humans; Medroxyprogesterone Acetate; Middle Aged; Patient Compliance; Young Adult	2015
Objective Measurement of Inaccurate Condom Use Reporting Among Women Using Depot Medroxyprogesterone Acetate for Contraception. AIDS and behavior, 2017, Volume: 21, Issue:7 Topics: Adult; Case-Control Studies; Chromosomes, Human, Y; Condoms; Contraception Behavior; Contraceptive Agents, Female; Cross-Sectional Studies; Delayed-Action Preparations; DNA; Female; HIV Infections; Humans; Medroxyprogesterone Acetate; Odds Ratio; Risk; Sexual Behavior; Sexual Partners; Vagina; Young Adult	2017
Genital Injury Signatures and Microbiome Alterations Associated With Depot Medroxyprogesterone Acetate Usage and Intravaginal Drying Practices. The Journal of infectious diseases, 2017, 02-15, Volume: 215, Issue:4 Topics: Adult; Carrier Proteins; Cell Adhesion Molecules; Contraceptive Agents, Female; Cross-Sectional Studies; Desiccation; Female; Gardnerella vaginalis; Hemoglobins; HIV; HIV Infections; Humans; Interleukin-1; Kenya; Medroxyprogesterone Acetate; Microbiota; Molecular Motor Proteins; Mucous Membrane; Myosin Heavy Chains; Phagocytosis; Receptors, Cell Surface; Receptors, Urokinase Plasminogen Activator; Risk Factors; Trefoil Factor-3; Tumor Suppressor Proteins; Vagina; Young Adult	2017
Effects of depot-medroxyprogesterone acetate on the immune microenvironment of the human cervix and endometrium: implications for HIV susceptibility. Mucosal immunology, 2017, Volume: 10, Issue:5 Topics: Adult; CD4-Positive T-Lymphocytes; Cellular Microenvironment; Cervix Uteri; Chemokine CCL2; Contraceptive Agents; Delayed-Action Preparations; Disease Susceptibility; Endometrium; Female; HIV Infections; Humans; Interferon-alpha; Interleukin-1beta; Interleukin-6; Medroxyprogesterone Acetate; Receptors, CCR5; Young Adult	2017
Incidence of sexually transmitted infections among HIV-infected women using depot medroxyprogesterone acetate contraception. Contraception, 2008, Volume: 78, Issue:2 Topics: Adult; Cohort Studies; Contraceptive Agents, Female; Drug Implants; Female; HIV Infections; Humans; Incidence; Medroxyprogesterone Acetate; Retrospective Studies; Sexually Transmitted Diseases	2008
Comment on "hormonal contraception and HIV prevalence in four African countries". Contraception, 2008, Volume: 78, Issue:4 Topics: Adolescent; Adult; Africa; Contraceptive Agents, Female; Female; HIV Infections; HIV Seroprevalence; Humans; Medroxyprogesterone Acetate; Prevalence; Sexual Behavior	2008
Hormonal contraception and metabolic outcomes in women with or at risk for HIV infection. Journal of acquired immune deficiency syndromes (1999), 2009, Volume: 52, Issue:5 Topics: Adolescent; Adult; Anti-HIV Agents; Cholesterol, HDL; Cohort Studies; Contraceptives, Oral, Hormonal; Drug Interactions; Estrogens; Female; Glucose Metabolism Disorders; HIV Infections; Humans; Lipid Metabolism Disorders; Medroxyprogesterone Acetate; Middle Aged; Progestins; Risk Factors; United States	2009
Low use and awareness of long-acting reversible contraception in women attending a South London genitourinary medicine clinic. International journal of STD & AIDS, 2010, Volume: 21, Issue:3 Topics: Adolescent; Adult; Contraceptive Agents, Female; Contraceptive Devices, Female; Female; Health Knowledge, Attitudes, Practice; HIV Infections; Humans; London; Medroxyprogesterone Acetate	2010
Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling. AIDS (London, England), 2010, Jul-17, Volume: 24, Issue:11 Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Epidemiologic Methods; Female; HIV Infections; HIV-1; Humans; Medroxyprogesterone Acetate; Young Adult	2010
Hormonal contraceptive use and HIV disease progression among women in Uganda and Zimbabwe. Journal of acquired immune deficiency syndromes (1999), 2011, Jun-01, Volume: 57, Issue:2 Topics: Adolescent; Adult; Contraceptives, Oral; Delayed-Action Preparations; Disease Progression; Female; HIV Infections; Humans; Medroxyprogesterone Acetate; Uganda; Young Adult; Zimbabwe	2011
Discontinuation of oral contraceptives and depot medroxyprogesterone acetate among women with and without HIV in Uganda, Zimbabwe and Thailand. Contraception, 2011, Volume: 83, Issue:6 Topics: Adolescent; Adult; Age Factors; Contraception Behavior; Contraceptives, Oral, Hormonal; Female; HIV Infections; Humans; Medroxyprogesterone Acetate; Prospective Studies; Reproductive History; Thailand; Uganda; Young Adult; Zimbabwe	2011
Hormonal contraception and HIV risk: evaluating marginal-structural-model assumptions. Epidemiology (Cambridge, Mass.), 2011, Volume: 22, Issue:6 Topics: Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Data Interpretation, Statistical; Delayed-Action Preparations; HIV Infections; Humans; Medroxyprogesterone Acetate; Models, Statistical; Risk Factors	2011
Sustained release of the CCR5 inhibitors CMPD167 and maraviroc from vaginal rings in rhesus macaques. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:5 Topics: Administration, Intravaginal; Animals; Anti-HIV Agents; Biopsy; CCR5 Receptor Antagonists; Chromatography, High Pressure Liquid; Contraceptive Devices, Female; Cyclohexanes; Delayed-Action Preparations; Female; HIV Infections; HIV-1; Humans; Longitudinal Studies; Macaca mulatta; Maraviroc; Medroxyprogesterone Acetate; Pyrazoles; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Tissue Distribution; Triazoles; Vagina; Valine; Virus Internalization	2012
Hormonal contraception and HIV acquisition risk: implications for individual users and public policies. Contraception, 2012, Volume: 86, Issue:6 Topics: Adolescent; Adult; Africa South of the Sahara; Contraception Behavior; Contraceptive Agents, Female; Drug Implants; Family Planning Services; Female; Health Policy; Health Promotion; HIV Infections; Humans; Male; Medroxyprogesterone Acetate; Middle Aged; Pregnancy; Pregnancy, Unwanted; Risk; Sex Workers; Sexual Behavior; Sexual Partners; Young Adult	2012
Effect of injectable contraceptive use on response to antiretroviral therapy among women in Rakai, Uganda. Contraception, 2012, Volume: 86, Issue:6 Topics: Adolescent; Adult; Anti-Retroviral Agents; Community Health Services; Contraceptive Agents, Female; Drug Implants; Drug Interactions; Drug Monitoring; Drug Resistance, Viral; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Lost to Follow-Up; Medication Adherence; Medroxyprogesterone Acetate; Uganda; Viral Load; Young Adult	2012
Hormonal contraception and HIV-1 infection: medroxyprogesterone acetate suppresses innate and adaptive immune mechanisms. Endocrinology, 2013, Volume: 154, Issue:3 Topics: Adaptive Immunity; Adult; Animals; Chemokines; Contraceptive Agents, Female; Cytokines; Female; HIV Infections; HIV-1; Humans; Immunity, Innate; Immunosuppressive Agents; Lymphocyte Activation; Medroxyprogesterone Acetate; Mice; Mice, Inbred C57BL; Mice, Transgenic; Receptors, CCR5; Receptors, CXCR4; T-Lymphocytes; Vagina; Virus Replication; Young Adult	2013
20 years, 20 articles: studies to know. Contraceptive technology update, 2000, Volume: 21, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Americas; Breast Feeding; Breast Neoplasms; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Developed Countries; Disease; Family Planning Services; Health; HIV Infections; Infant Nutritional Physiological Phenomena; Intrauterine Devices; Lactation; Medroxyprogesterone Acetate; Neoplasms; North America; Nutritional Physiological Phenomena; Research; Sterilization, Reproductive; Sterilization, Tubal; United States; Virus Diseases	2000
The early work on hormonal contraceptive use and HIV acquisition. Journal of acquired immune deficiency syndromes (1999), 2005, Volume: 38 Suppl 1 Topics: Cohort Studies; Contraception; Contraceptive Agents, Female; Female; History, 20th Century; HIV Infections; HIV-1; Humans; Kenya; Male; Medroxyprogesterone Acetate; Prospective Studies; Risk Factors; Sex Work	2005
Progestin-based contraceptive suppresses cellular immune responses in SHIV-infected rhesus macaques. Virology, 2006, Aug-15, Volume: 352, Issue:1 Topics: Animals; Contraceptive Agents, Female; Disease Susceptibility; Female; HIV Infections; HIV-1; Humans; Interferon-gamma; Lymphocyte Activation; Macaca mulatta; Medroxyprogesterone Acetate; Progestins; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; T-Lymphocytes; Viral Load; Virus Replication	2006
Hormonal contraception and the risk of HIV acquisition. AIDS (London, England), 2007, Jan-02, Volume: 21, Issue:1 Topics: Adult; Confidence Intervals; Contraception Behavior; Contraceptives, Oral, Hormonal; Delayed-Action Preparations; Disease Transmission, Infectious; Female; Herpes Simplex; Herpesvirus 2, Human; HIV; HIV Infections; Humans; Male; Medroxyprogesterone Acetate; Middle Aged; Proportional Hazards Models; Prospective Studies; Risk; Thailand; Uganda; Zimbabwe	2007
Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. The Journal of infectious diseases, 2007, Mar-01, Volume: 195, Issue:5 Topics: Adult; Alcohol Drinking; Delayed-Action Preparations; Education; Female; HIV Infections; HIV-1; Humans; Kenya; Levonorgestrel; Medroxyprogesterone Acetate; Risk Factors; Sex Work; Time Factors; Trichomonas Vaginitis	2007
Hormonal contraception and HIV-1 disease progression among postpartum Kenyan women. AIDS (London, England), 2007, Mar-30, Volume: 21, Issue:6 Topics: Adult; CD4 Lymphocyte Count; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Delayed-Action Preparations; Disease Progression; Female; HIV Infections; HIV-1; Humans; Kenya; Medroxyprogesterone Acetate; Postpartum Period; Prospective Studies; RNA, Viral; Time Factors; Viral Load	2007
Hormonal contraception and HIV prevalence in four African countries. Contraception, 2008, Volume: 77, Issue:5 Topics: Adolescent; Adult; Africa; Contraceptive Agents, Female; Female; HIV Infections; HIV Seroprevalence; Humans; Medroxyprogesterone Acetate	2008
SIV transmission. Monkey study prompts high-level public health response. Science (New York, N.Y.), 1996, May-10, Volume: 272, Issue:5263 Topics: Animals; Contraceptive Agents, Female; Disease Models, Animal; Epithelium; Female; Haplorhini; HIV Infections; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Progesterone; Risk Factors; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Vagina	1996